Stay updated on BBP-398 + Osimertinib in EGFR+ NSCLC: Clinical Trial

Sign up to get notified when there's something new on the BBP-398 + Osimertinib in EGFR+ NSCLC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BBP-398 + Osimertinib in EGFR+ NSCLC: Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Introducing a major operational notice about funding status and updated versioning to v3.2.0, while removing the previous v3.1.0 reference.
    Difference
    4%
    Check dated 2025-10-07T23:09:52.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Updated the page from Revision: v3.0.2 to Revision: v3.1.0, signaling a new software version.
    Difference
    0.1%
    Check dated 2025-09-30T01:36:52.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Update to v3.0.2 replacing v3.0.1; removal of the 'Back to Top' link; no other substantive changes.
    Difference
    0.2%
    Check dated 2025-09-15T19:14:22.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.2%
    Check dated 2025-09-07T13:36:28.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and specific location details in Beijing, while several related terms and categories have been removed, including various medical classifications and the previous version number.
    Difference
    3%
    Check dated 2025-08-31T11:33:38.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-08-17T01:36:10.000Z thumbnail image

Stay in the know with updates to BBP-398 + Osimertinib in EGFR+ NSCLC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BBP-398 + Osimertinib in EGFR+ NSCLC: Clinical Trial page.